Delivery Order SPE2DE22D0008-SPE2D625F2J9Q

Award Date 4/10/25
Potential Completion Date 6/13/25
Potential Value $11K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Chicago, IL 60607, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of ALBACYTE antibody screening (3-cell) products to the Defense Logistics Agency (DLA). The contract, valued at $1,281.00, was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, and other biomedical products to various federal agencies, including the Department of Veterans Affairs (VA) and the Department of Health and Human Services (HHS). The...
This federal contract award SPE2DE22D0008|SPE2D625F22W7 was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a foreign-owned, for-profit organization specializing in in vitro diagnostics, blood bank reagents, and quality control materials. The $5,160.00 firm fixed-price delivery order contract is for the provision of ALBACYTE antibody identification panels, a critical product supporting blood banking operations across federal healthcare systems. Alba Bioscience, a...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The contract was awarded by the Defense Logistics Agency (DLA) and has a ceiling value of $17,441.00. It is a Delivery Order contract with a Firm Fixed Price pricing type. The contract is for the supply of ALBACLONE Anti-P1 medical products, which are likely critical blood banking supplies supporting diagnostic testing, blood typing, and...
This federal contract award, valued at $2,370.00, was issued by the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking reagents. The award is a Delivery Order contract for the supply of ALBACLONE Anti-A products. This contract is not set aside for any specific type of small business. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc. and has a history of providing specialized medical...
This federal contract award with ID SPE2DE22D0008|SPE2D625F23XA was issued by the Defense Logistics Agency's (DLA) Medical Supply Chain to Alba Bioscience, Inc., a for-profit organization and subsidiary of Quotient Biodiagnostics, Inc. The $22,550.00 firm fixed-price contract is for the delivery of ALBACLONE Anti-D Blend products, which are specialized blood banking reagents and diagnostic materials used for blood typing and transfusion services in federal healthcare facilities. The contract...
This is a federal contract award to Alba Bioscience, Inc., a for-profit medical supply company, by the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is for the delivery of ALBACYTE antibody screening tests, with a ceiling value of $2,520.00 and a period of performance through April 15, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation. Alba Bioscience, Inc. is a subsidiary of Quotient Biodiagnostics, Inc. and is a leading supplier of...
This is a federal contract award to Alba Bioscience, Inc., a for-profit organization specializing in in vitro diagnostics and blood banking products. The contract, worth $1,740.00, is a delivery order under contract SPE2DE22D0008|SPE2D625F15SJ, awarded by the Defense Logistics Agency's (DLA) Medical Supply Chain. The contract is for the supply of ALBACYTE Antibody ID Panels, which are specialized 16-cell panels used for antibody identification in blood banking operations. This contract does...
This federal contract award is for the delivery of ALBACYTE antibody screening tests (3-cell) to the Defense Logistics Agency (DLA). The $1,281.00 firm-fixed-price contract was awarded to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in in vitro diagnostics, blood bank reagents, and quality control materials. The award is not associated with a set-aside program and serves as a delivery order under the company's existing federal contract vehicles, including a...
This federal contract award to Alba Bioscience, Inc., a foreign-owned for-profit organization, is for the supply of specialized in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials. The contract, valued at $6,750.00, was awarded by the Defense Logistics Agency (DLA) Medical Supply Chain division to support defense medical operations. The contract is a delivery order under a larger Indefinite Delivery Vehicle (IDV), likely a Blanket Purchase Agreement...
This federal contract award, valued at $2,378.29, was issued by the Defense Logistics Agency (DLA) Medical Supply Chain to Alba Bioscience, Inc., a foreign-owned, for-profit organization that specializes in providing in vitro diagnostics, blood bank reagents, antibody screening tests, and quality control materials to various U.S. government agencies. The contract is a delivery order for the ALBACYTE Antibody Screen (3-cell), a critical blood banking product used to support medical operations...
  • SPE2DE22D0008
    Indefinite Delivery Contract
  • SPE2DE22D0008-SPE2D625F2J9Q
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to Alba Bioscience, Inc., a subsidiary of Quotient Biodiagnostics, Inc. The contract is for the delivery of ALBACYTE antibody identification panels, which are in vitro diagnostic products used in blood banking operations across various government agencies, including the Department of Veterans Affairs (VA), Defense Health Agency (DHA), and National Institutes of Health (NIH).

The contract is a Delivery Order with a Firm Fixed Price of $11,323.00 and a performance period through June 13, 2025. Alba Bioscience, Inc. is an experienced supplier of specialized blood banking products to federal healthcare systems, holding multiple Blanket Purchase Agreements (BPAs) with the VA. This contract was awarded without any set-aside designation, indicating Alba Bioscience's competitive position in providing these critical medical supplies to the government.

Generated 7/17/25, 6:00 PM